Neurogene (NGNE) Prepaid Assets (2013 - 2026)

Neurogene posted quarterly Prepaid Assets of $3.6 million for Q1 2026, up 257.57% year-on-year from $997000.0 in Q1 2025, and up 29.31% on a QoQ basis from $2.8 million in Q4 2025.

Neurogene (NGNE) has 10 years of Prepaid Assets data on file, last reported at $3.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets rose 257.57% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (up 257.57% YoY), and the FY2025 full-year result was $2.8 million, down 21.63% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $3.6 million, up from $2.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.1 million in Q3 2025 and bottomed at $630000.0 in Q4 2022.
  • The 5-year median for Prepaid Assets is $2.0 million (2022), against an average of $2.2 million.
  • The widest annual swing landed in 2022, when Prepaid Assets tumbled 58.61%; it then surged 406.51% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $630000.0 in 2022, then soared by 406.51% to $3.2 million in 2023, then climbed by 10.25% to $3.5 million in 2024, then slipped by 21.63% to $2.8 million in 2025, then increased by 29.31% to $3.6 million in 2026.
  • The last three Prepaid Assets figures came in at $3.6 million (Q1 2026), $2.8 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Neurogene 632.14 Mn 632.14 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.57 Mn
Dec 31, 2025 2.76 Mn
Sep 30, 2025 5.11 Mn
Jun 30, 2025 970,000.00
Mar 31, 2025 997,000.00
Dec 31, 2024 3.52 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 1.53 Mn
Mar 31, 2024 1.25 Mn
Dec 31, 2023 3.19 Mn
Sep 30, 2023 1.39 Mn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 2.20 Mn
Dec 31, 2022 630,000.00
Sep 30, 2022 1.98 Mn
Jun 30, 2022 2.03 Mn
Mar 31, 2022 2.31 Mn
Dec 31, 2021 1.52 Mn
Sep 30, 2021 1.57 Mn
Jun 30, 2021 3.26 Mn
Mar 31, 2021 2.92 Mn
Dec 31, 2020 1.97 Mn
Sep 30, 2020 5.44 Mn
Jun 30, 2020 1.40 Mn
Dec 31, 2019 503,000.00
Sep 30, 2014 283,853.00
Jun 30, 2014 424,240.00
Mar 31, 2014 547,812.00
Dec 31, 2013 63,975.00